Improving Diagnostic Clarity: Why Heavy Metal Assessment is Incomplete Without HTMA

Part 2 of Improving Diagnostic Clarity, this session shifts the focus to heavy metals and HTMA as a biomarker of body burden. We’ll explore why blood and spot urine testing often miss chronic, low-grade exposure, and how hair tissue mineral analysis offers a longer-term view of metals such as lead, mercury, cadmium and arsenic. The lecture will cover key interpretation principles, common pitfalls and how to integrate HTMA with existing bloods to decide if, when and how to address toxic load. Emphasis is on clinical safety, sequencing mineral repletion, detox support and
follow-up testing